Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Agios Pharm

AGIO
Current price
44.14 USD +0.57 USD (+1.31%)
Last closed 43.7 USD
ISIN US00847X1046
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 2 426 490 880 USD
Yield for 12 month +102.38 %
1Y
3Y
5Y
10Y
15Y
AGIO
21.11.2021 - 28.11.2021

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts. Address: 88 Sidney Street, Cambridge, MA, United States, 02139

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

56.2 USD

P/E ratio

Dividend Yield

Current Year

+26 823 000 USD

Last Year

+14 240 000 USD

Current Quarter

+8 615 000 USD

Last Quarter

+8 189 000 USD

Current Year

+17 319 000 USD

Last Year

+12 536 000 USD

Current Quarter

+5 527 000 USD

Last Quarter

+6 214 000 USD

Key Figures AGIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -399 096 000 USD
Operating Margin TTM -1228.29 %
PE Ratio
Return On Assets TTM -27.25 %
PEG Ratio
Return On Equity TTM -44.92 %
Wall Street Target Price 56.2 USD
Revenue TTM 31 306 000 USD
Book Value 11.61 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 28.4 %
Dividend Yield
Gross Profit TTM 12 536 000 USD
Earnings per share -6.5 USD
Diluted Eps TTM -6.5 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics AGIO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AGIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation AGIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 2.4655
Enterprise Value Revenue 61.3691
Price Sales TTM 77.5088
Enterprise Value EBITDA -2.3282
Price Book MRQ 3.6737

Financials AGIO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AGIO

For 52 weeks

19.8 USD 53.29 USD
50 Day MA 44.55 USD
Shares Short Prior Month 2 976 882
200 Day MA 36.27 USD
Short Ratio 6.09
Shares Short 3 275 023
Short Percent 5.84 %